Anemic copper-deficient rats, but not mice, display low hepcidin expression and high ferroportin levels
- PMID: 20164366
- PMCID: PMC2838621
- DOI: "VSports手机版" 10.3945/jn.109.117077
Anemic copper-deficient rats, but not mice, display low hepcidin expression and high ferroportin levels
Abstract
The transmembrane protein ferroportin (Fpn) is essential for iron efflux from the liver, spleen, and duodenum. Fpn is regulated predominantly by the circulating iron regulatory hormone hepcidin, which binds to cell surface Fpn, initiating its degradation. Accordingly, when hepcidin concentrations decrease, Fpn levels increase VSports手机版. A previous study found that Fpn levels were not elevated in copper-deficient (CuD) mice that had anemia, a condition normally associated with dramatic reductions in hepcidin. Lack of change in Fpn levels may be because CuD mice do not display reduced concentrations of plasma iron (holotransferrin), a modulator of hepcidin expression. Here, we examined Fpn protein levels and hepcidin expression in CuD rats, which exhibit reduced plasma iron concentrations along with anemia. We also examined hepcidin expression in anemic CuD mice with normal plasma iron levels. We found that CuD rats had higher liver and spleen Fpn levels and markedly lower hepatic hepcidin mRNA expression than did copper-adequate (CuA) rats. In contrast, hepcidin levels did not differ between CuD and CuA mice. To examine potential mediators of the reduced hepcidin expression in CuD rats, we measured levels of hepatic transferrin receptor 2 (TfR2), a putative iron sensor that links holotransferrin to hepcidin production, and transcript abundance of bone morphogenic protein 6 (BMP6), a key endogenous positive regulator of hepcidin production. Diminished hepcidin expression in CuD rats was associated with lower levels of TfR2, but not BMP6. Our data suggest that holotransferrin and TfR2, rather than anemia or BMP6, are signals for hepcidin synthesis during copper deficiency. .
Figures






V体育2025版 - References
-
- Danks DM. Copper deficiency in humans. Annu Rev Nutr. 1988;8:235–57. - "VSports app下载" PubMed
-
- Videt-Gibou D, Belliard S, Bardou-Jacquet E, Troadec MB, Le Lan C, Jouanolle AM, Loreal O, Rivalan J, Brissot P. Iron excess treatable by copper supplementation in acquired aceruloplasminemia: a new form of secondary human iron overload? Blood. 2009;114:2360–1. - "VSports在线直播" PubMed
-
- Fox PL. The copper-iron chronicles: the story of an intimate relationship. Biometals. 2003;16:9–40. - PubMed
-
- Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275:19906–12. - "V体育2025版" PubMed
-
- McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309. - "VSports在线直播" PubMed
Publication types
- VSports app下载 - Actions
"VSports手机版" MeSH terms
- Actions (V体育平台登录)
- V体育官网 - Actions
- VSports手机版 - Actions
- "V体育2025版" Actions
- VSports - Actions
- "V体育平台登录" Actions
- Actions (V体育2025版)
- Actions (VSports注册入口)
- Actions (VSports在线直播)
- "V体育安卓版" Actions
- Actions (VSports在线直播)
- Actions (V体育官网)
- Actions (V体育官网入口)
- "VSports注册入口" Actions
Substances
- "V体育2025版" Actions
- "VSports最新版本" Actions
- Actions (V体育2025版)
- Actions (VSports)